Transcutaneous Auricular Neurostimulation (tAN™) for Opioid Withdrawal Selected as a Top Abstract by American Society of Pain and Neuroscience
This is some text inside of a div block.
Spark Biomedical, Inc, CARMAhealth, and Recovery Unplugged jointly developed abstract places second in the American Society of Pain and Neuroscience (ASPN) 2020 Annual Conference. The abstract entitled, Interim Results from a Randomized, Double-Blind, Controlled Trial Examining Use of Transcutaneous Auricular Neurostimulation (tAN) to Improve Symptoms Associated with Opioid Withdrawal, outlines initial results from the first 20 patients in the clinical trial targeting participants with opioid use disorder.
